SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Shree Ganesh Remedies informs about outcome of board meeting

22 Aug 2020 Evaluate

Pursuant to Regulations 30 and 42 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘Listing Regulations’) read with Schedule III to the said Regulations, Shree Ganesh Remedies has informed that the Board of Directors of the Company, at its Meeting held on Friday, August 21, 2020 (which commenced at 03.30 pm and concluded at 04:30 pm), have approved/ noted various matters as details are enclosed.

The above information is a part of company’s filings submitted to BSE.

Shree Ganesh Remed. Share Price

533.90 26.70 (5.26%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×